LDHA is a direct target of miR‐30d‐5p and contributes to aggressive progression of gallbladder carcinoma

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Molecular Carcinogenesis

• Publication date

  2018-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/mc.22799PMID 29569755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect.

  2017cited by this paper
• Efficacy and Safety of Capecitabine, Irinotecan, Gemcitabine, and Bevacizumab as Second-Line Treatment in Advanced Biliary Tract Cancer: A Phase II Study

  2017cited by this paper
• Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update

  2017cited by this paper
• MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A

  2017cited by this paper
• PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a

  2017cited by this paper
• A Predictive Model for Selective Targeting of the Warburg Effect through GAPDH Inhibition with a Natural Product.

  2017cited by this paper
• The Warburg effect as an adaptation of cancer cells to rapid fluctuations in energy demand

  2017cited by this paper
• miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma

  2016cited by this paper
• Up-regulation of PKM2 promote malignancy and related to adverse prognostic risk factor in human gallbladder cancer

  2016influential reference
• Fundamentals of cancer metabolism

  2016cited by this paper
• MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A

  2016cited by this paper
• Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening

  2016cited by this paper
• HPV E6/p53 mediated down-regulation of miR-34a inhibits Warburg effect through targeting LDHA in cervical cancer.

  2016cited by this paper
• miR-383 inhibits ovarian cancer cell proliferation, invasion and aerobic glycolysis by targeting LDHA.

  2016cited by this paper
• Long-Term Outcomes and Prognostic Factors in Advanced Gallbladder Cancer: Focus on the Advanced T Stage

  2016cited by this paper
• Suppression of lactate dehydrogenase A compromises tumor progression by downregulation of the Warburg effect in glioblastoma

  2016cited by this paper
• MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer.

  2015cited by this paper
• MiR‐199a‐5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer

  2015cited by this paper
• The c-Myc–LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer

  2015cited by this paper
• Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer

  2015cited by this paper
• Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function.

  2015cited by this paper
• Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells.

  2014cited by this paper
• Gallbladder cancer: epidemiology and outcome

  2014cited by this paper
• Different effects of LDH-A inhibition by oxamate in non-small cell lung cancer cells

  2014cited by this paper
• MicroRNA‐1 (miR‐1) inhibits chordoma cell migration and invasion by targeting slug

  2014cited by this paper
• Lactate Dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma

  2014cited by this paper
• FOXM1 Promotes the Warburg Effect and Pancreatic Cancer Progression via Transactivation of LDHA Expression

  2014cited by this paper
• Relationships between LDH-A, Lactate, and Metastases in 4T1 Breast Tumors

  2013cited by this paper
• Lactate dehydrogenase a in cancer: A promising target for diagnosis and therapy

  2013cited by this paper
• Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer.

  2013cited by this paper
• Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression

  2013cited by this paper
• ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect

  2012cited by this paper
• Roles of microRNA on cancer cell metabolism

  2012cited by this paper
• Using association rules mining to explore pattern of Chinese medicinal formulae (prescription) in treating and preventing breast cancer recurrence and metastasis

  2012cited by this paper
• Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma

  2012cited by this paper
• Development of molecularly targeted therapies in biliary tract cancers: Reassessing the challenges and opportunities

  2011cited by this paper
• A Combined Proteomics and Metabolomics Profiling of Gastric Cardia Cancer Reveals Characteristic Dysregulations in Glucose Metabolism*

  2010cited by this paper
• Analysis of Gene Expression Data Using BRB-Array Tools

  2007cited by this paper
• Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation

  2002cited by this paper

• The signal hijacker: How tumors co-opt chemical, electrical, and mechanical cues to thrive.

  2026cites this paper
• Stage-Specific miRNA Profiling Reveals Key Regulators of EMT and EGFR-TKI Resistance in Gallbladder Cancer

  2026cites this paper
• Energy metabolism in health and diseases

  2025cites this paper
• Lactylation in digestive system tumors: from mechanisms to therapeutic target

  2025cites this paper
• Fasting inhibits glycolysis and migration/invasion in gallbladder cancer via PCBP2/ANGPTL4 signaling

  2025cites this paper
• Lactylation in Cancer: Unlocking the Key to Drug Resistance and Therapeutic Breakthroughs

  2025cites this paper
• Daily Profile of miRNAs in the Rat Colon and In Silico Analysis of Their Possible Relationship to Colorectal Cancer

  2025cites this paper
• Protein lactylation and immunotherapy in gliomas: A novel regulatory axis in tumor metabolism (Review)

  2025cites this paper
• Investigation of the synergistic effect of metformin and FX11 on PANC-1 cell lines

  2025cites this paper
• Fasting-induced RNF152 resensitizes gallbladder cancer cells to gemcitabine by inhibiting mTORC1-mediated glycolysis

  2024cites this paper
• Epigenetic silencing of LDHB promotes hepatocellular carcinoma by remodeling the tumor microenvironment

  2024cites this paper
• LDHA as a predictive biomarker and its association with the infiltration of immune cells in pancreatic adenocarcinoma

  2024cites this paper
• OIP5-AS1 enhances the malignant characteristics and resistance to chemotherapy of pancreatic cancer cells by targeting miR-30d-5p/MARCH8

  2024cites this paper
• miRNAs orchestration of gallbladder cancer - Particular emphasis on diagnosis, progression and drug resistance.

  2023cites this paper
• miRNA-Based Technologies in Cancer Therapy

  2023cites this paper
• Unmasking the Warburg Effect: Unleashing the Power of Enzyme Inhibitors for Cancer Therapy

  2023cites this paper
• Blood exosome marker miRNA-30d-5p: Role and regulation mechanism in progression and gemcitabine resistance of hepatocellular carcinoma.

  2023cites this paper
• Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects

  2022cites this paper
• Targeting Energy Metabolism in Cancer Treatment

  2022cites this paper
• LINC01128 facilitates the progression of pancreatic cancer through up-regulation of LDHA by targeting miR-561-5p

  2022cites this paper
• Noncoding ribonucleic acids in gallbladder cancer patients

  2022cites this paper
• miR-30d-5p: A Non-Coding RNA With Potential Diagnostic, Prognostic and Therapeutic Applications

  2022influential citation
• Non-coding RNAs as potential biomarkers of gallbladder cancer

  2022cites this paper
• LDHA: The Obstacle to T cell responses against tumor

  2022cites this paper
• Screening Tumor-Related Genes of Gallbladder Cancer Based on AR-Based Tumor Expression Profile Gene Chip

  2022cites this paper
• lncRNA MANCR Inhibits NK Cell Killing Effect on Lung Adenocarcinoma by Targeting miRNA-30d-5p

  2022cites this paper
• MicroRNA-mediated reprogramming of glucose, fatty acid and amino acid metabolism in cancer

  2022cites this paper
• Prognostic capacity of the transcriptional expression of lactate dehydrogenase A in patients with head and neck squamous cell carcinoma

  2022cites this paper
• The Role of LINC00284 in the Development of Thyroid Cancer via Its Regulation of the MicroRNA-30d-5p-Mediated ADAM12/Notch Axis

  2021cites this paper
• LncRNA DDX11 antisense RNA 1 promotes EMT process of esophageal squamous cell carcinoma by sponging miR-30d-5p to regulate SNAI1/ZEB2 expression and Wnt/β-catenin pathway

  2021cites this paper
• Reiterating the Emergence of Noncoding RNAs as Regulators of the Critical Hallmarks of Gall Bladder Cancer

  2021cites this paper
• MicroRNA-30d target TIMP3 induces pituitary tumor cell growth and invasion.

  2021cites this paper
• Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes

  2021cites this paper
• The metabolism of cancer cells during metastasis

  2021cites this paper
• Targeting Cancer Metabolism and Current Anti-Cancer Drugs.

  2021cites this paper
• ELK1 Promotes Epithelial-Mesenchymal Transition and the Progression of Lung Adenocarcinoma by Upregulating B7-H3

  2021cites this paper
• Novel biomarkers for the diagnosis and prognosis of gallbladder cancer

  2020cites this paper
• Aberrant CDK9 expression within chordoma tissues and the therapeutic potential of a selective CDK9 inhibitor LDC000067

  2020cites this paper
• P4HA2 contributes to cervical cancer progression via inducing epithelial-mesenchymal transition

  2020cites this paper
• Original Article/Liver hMex-3A is associated with poor prognosis and contributes to the progression of hepatocellular carcinoma.

  2020cites this paper
• E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway

  2020cites this paper
• Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma

  2020cites this paper
• Alterations in glycolytic/cholesterogenic gene expression in hepatocellular carcinoma

  2020cites this paper
• circ_BICD2 acts as a ceRNA to promote tumor progression and Warburg effect in oral squamous cell carcinoma by sponging miR-107 to enhance HK2.

  2020cites this paper
• A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR‐30d‐5p/HDAC9 axis and the epithelial–mesenchymal transition

  2020cites this paper
• Regulation of Glycolysis by Non-coding RNAs in Cancer: Switching on the Warburg Effect

  2020cites this paper
• miR‐30d‐5p suppresses proliferation and autophagy by targeting ATG5 in renal cell carcinoma

  2020cites this paper
• A systematic review with in silico analysis on transcriptomic profile of gallbladder carcinoma.

  2020cites this paper
• The microRNA cluster miR-30b/-30d prevents tumor cell switch from an epithelial to a mesenchymal-like phenotype in GBC

  2020influential citation
• Conformational Changes of Lactate Dehydrogenase Isozymes

  2020cites this paper
• LDHA-MA

  2019cites this paper
• LDHA Promotes Oral Squamous Cell Carcinoma Progression Through Facilitating Glycolysis and Epithelial–Mesenchymal Transition

  2019cites this paper
• MicroRNA-30d-5p promotes ovarian granulosa cell apoptosis by targeting Smad2

  2019cites this paper
• MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities

  2019cites this paper
• UCP2 promotes proliferation and chemoresistance through regulating the NF-κB/β-catenin axis and mitochondrial ROS in gallbladder cancer.

  2019cites this paper
• Bile-derived circulating extracellular miR-30d-5p and miR-92a-3p as potential biomarkers for cholangiocarcinoma.

  2019cites this paper
• The roles of glucose metabolic reprogramming in chemo- and radio-resistance

  2019cites this paper
• Overexpression of CBX 2 in breast cancer promotes tumor progression through the PI 3 K / AKT signaling pathway

  2019cites this paper
• A novel 4-gene signature for overall survival prediction in lung adenocarcinoma patients with lymph node metastasis

  2019cites this paper
• Overexpression of CBX2 in breast cancer promotes tumor progression through the PI3K/AKT signaling pathway.

  2019cites this paper
• Thrombospondin-4 expression as a prognostic marker in hepatocellular carcinoma.

  2019cites this paper
• Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer

  2019cites this paper
• MiR-1-5p is down-regulated in gallbladder carcinoma and suppresses cell proliferation, migration and invasion by targeting Notch2.

  2019cites this paper
• New avenues in pancreatic cancer: exploiting microRNAs as predictive biomarkers and new approaches to target aberrant metabolism

  2019cites this paper
• High expression of long non-coding RNA NNT-AS1 facilitates progression of cholangiocarcinoma through promoting epithelial-mesenchymal transition.

  2019cites this paper
• Upregulation of the long non-coding RNA FOXD2-AS1 is correlated with tumor progression and metastasis in papillary thyroid cancer.

  2019cites this paper
• Combined Aberrant Expression of NDRG2 and LDHA Predicts Hepatocellular Carcinoma Prognosis and Mediates the Anti-tumor Effect of Gemcitabine

  2019cites this paper
• Long noncoding RNA CASC15 predicts unfavorable prognosis and exerts oncogenic functions in non-small cell lung cancer.

  2019cites this paper
• Machilin A Inhibits Tumor Growth and Macrophage M2 Polarization Through the Reduction of Lactic Acid

  2019cites this paper
• Silencing of the long non-coding RNA RHPN1-AS1 suppresses the epithelial-to-mesenchymal transition and inhibits breast cancer progression.

  2019cites this paper
• CBX2 is a functional target of miRNA let‐7a and acts as a tumor promoter in osteosarcoma

  2019cites this paper
• The Multiple Molecular Signatures in Gallbladder Carcinoma: from Basic Studies to Clinical Application

  2019cites this paper
• Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment

  2019cites this paper
• Development of novel human lactate dehydrogenase A inhibitors: High-throughput screening, synthesis, and biological evaluations.

  2019cites this paper
• CD44 is overexpressed and correlated with tumor progression in gallbladder cancer

  2018cites this paper
• Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy

  2018cites this paper
• Low expression of LACTB promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma.

  2018cites this paper
• Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients

  2018cites this paper
• Inhibition of microRNA-30d attenuates the apoptosis and extracellular matrix degradation of degenerative human nucleus pulposus cells by up-regulating SOX9.

  2018cites this paper
• Downregulation of PIM1 regulates glycolysis and suppresses tumor progression in gallbladder cancer

  2018cites this paper
• RETRACTED ARTICLE: Downregulation of PIM1 regulates glycolysis and suppresses tumor progression in gallbladder cancer

  year unknowncites this paper